Global Cancer Statistics 2020 : GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Open access full text Check availability: Full text (publisher site)

Abstract

This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer. Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. Overall incidence was from 2-fold to 3-fold higher in transitioned versus transitioning countries for both sexes, whereas mortality varied

Saved in:
Authors: Hyuna Sung iD (American Cancer Society); Adalberto M. Filho iD (Centre international de recherche sur le cancer); Mathieu Laversanne iD (American Cancer Society; Centre international de recherche sur le cancer); Jacques Ferlay iD (Centre international de recherche sur le cancer); Rebecca L. Siegel iD (American Cancer Society; Centre international de recherche sur le cancer); Isabelle Soerjomataram iD (American Cancer Society; Centre international de recherche sur le cancer); Ahmedin Jemal iD (American Cancer Society; Centre international de recherche sur le cancer); Freddie Bray iD (Centre international de recherche sur le cancer)
Published in: CA A Cancer Journal for Clinicians, vol. 71, no. 3, pp. 209-249
Publication date:04/02/2021
Publisher:Wiley
Document type:Article
Language:English
DOI: 10.3322/caac.21660
ISSN:0007-9235, 1542-4863
Open access: Open access Gold: open access journal – CA A Cancer Journal for Clinicians
Cited by:108,391
Subjects:
Global Cancer Incidence and Screening (Health Sciences > Medicine > Oncology)
Economic and Financial Impacts of Cancer (Social Sciences > Economics, Econometrics and Finance > Economics and Econometrics)
Advances in Oncology and Radiotherapy (Health Sciences > Medicine > Radiology, Nuclear Medicine and Imaging)
global cancer burden, cancer incidence, cancer mortality, female breast cancer, lung cancer, colorectal cancer, prostate cancer, gastric cancer, cervical cancer, global cancer control
Identifiers: OpenAlex W3128646645 · PMID 33538338

Central index data: OpenAlex (CC0 license).

Summary:This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer. Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. Overall incidence was from 2-fold to 3-fold higher in transitioned versus transitioning countries for both sexes, whereas mortality varied
ISSN:0007-9235
1542-4863
DOI:10.3322/caac.21660